XHANCE resources for healthcare professionals
Mechanism of Delivery and Polyp Reduction






Peer Insights




Patient Testimonials

Paid Spokesperson

Paid Spokesperson
CONTRAINDICATIONS:
Hypersensitivity to any ingredient in XHANCE.
WARNINGS AND PRECAUTIONS:
ADVERSE REACTIONS:
The most common adverse reactions (incidence ≥ 3%) are epistaxis, nasal septal ulceration, nasopharyngitis, nasal mucosal erythema, nasal mucosal ulcerations, nasal congestion, acute sinusitis, nasal septal erythema, headache, and pharyngitis.
DRUG INTERACTIONS:
Strong cytochrome P450 3A4 inhibitors (e.g., ritonavir, ketoconazole): Use not recommended. May increase risk of systemic corticosteroid effects.
USE IN SPECIFIC POPULATIONS:
Hepatic impairment. Monitor patients for signs of increased drug exposure.
INDICATION AND USAGE: XHANCE is a corticosteroid indicated for the treatment of nasal polyps in patients 18 years of age or older.
Please see full Prescribing Information, including Instructions for Use.